| ADL |
Activities of Daily Living |
| ADR |
Adverse Drug Reaction |
| AE |
Adverse Events or Experience |
| AER |
Adverse Experience Report |
| AIDS |
Acquired Immunodeficiency Syndrome |
| ART |
Antiretroviral Therapy |
| CAB |
Community Advisory Board |
| CBO |
Community-Based Organization |
| CCG |
Community Constituency Group (AACTG & PACTG) |
| CFR |
Code of Federal Regulations |
| CL |
Central Laboratory |
| CP |
Concept Plan |
| CPA |
Cooperative Project Assurance |
| CPRP |
Cooperative Protocol Research Program |
| CRF |
Case Report Form |
| CS |
Concept Sheet |
| CSW |
Commercial Sex Worker |
| CTA |
Clinical Trials Agreement |
| CTAAG |
Clinical Trials At A Glance Report |
| CTS |
Clinical Trials Specialist |
| FOIA |
Freedom of Information Act |
| FTP |
File Transfer Protocol |
| FY |
Fiscal Year |
| GCAB |
Global Community Advisory Board (formerly NCAB) |
| GCP |
Good Clinical Practice |
| GLP |
Good Laboratory Practice |
| HIV |
Human Immunodeficiency Virus |
| IND |
Investigational New Drug |
| loR |
Investigator of Record |
| IRB |
Institutional Review Board |
| LFU |
Lost to Followup |
| LOU |
Letter of Understanding |
| MAPS |
Master Antiretroviral Protocol Strategy |
| MIS |
Management Information System |
| MM |
Medical Monitor |
| MO |
Medical Officer |
| MOP |
Manual of Operations |
| MOPPS |
Multiple Opportunistic Pathogens Prophylaxis |
| MOU |
Memo of Understanding |
| MPA |
Multiple Project Insurance |
| NDA |
New Drug Application |
| NWCS |
New Work Concept Sheet |
| PAB |
Pharmaceutical Affairs Branch |
| PC |
Project Coordinator |
| PI |
Principal Investigator |
| PID |
Patient Identification Number |
| PLWA |
Person Living With AIDS |
| PSR |
Protocol Status Report |
| PSRC |
Prevention Sciences Review Committee |
| PT |
Protocol Team |
| PWA |
Person With AIDS |
| PWG |
Protocol Working Group |
| QA |
Quality Assurance |
| QC |
Quality Control |
| QOL |
Quality of Life |
| RA |
Regulatory Affairs |
| RCT |
Randomized Control Trial |
| RFA |
Request for Applications |
| RFP |
Request for Proposals |
| SAE |
Serious Adverse Event/Experience |
| SC |
HVTN Statistical Center (SCHARP) |
| SEG |
Special Emphasis Group (Laboratory) |
| SID |
Study Identification Number |
| SIV |
Simian Immunodeficiency Virus |
| SMC |
Site Monitoring Committee |
| SOP |
Standard Operating Procedure |
| SPA |
Site Project Assurance |
| SSC |
Scientific Steering Committee (HVTN) |
| VLG |
Vaccine Leadership Group |
